Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Potential new naturally produced anti-HIV agents with CCR5-antagonist activity

Dec. 4, 2001

Amerimmune's novel HIV treatment completes phase Ia trial

Dec. 4, 2001

Epimmune and Bavarian Nordic collaborate to develop HIV vaccines

Dec. 4, 2001

Parker Hughes Institute continues R&D on thiophene-substituted thiourea anti-HIV agents

Nov. 27, 2001

HIV protease inhibitors claimed in recent patent by Pharmacor team

Nov. 22, 2001

NIH awards two grants to Progenics for development of innovative HIV therapies

Nov. 16, 2001

Status of Tibotec-Virco next-generation anti-HIV drugs updated in Athens

Nov. 12, 2001

GSK's Trizivir receives Health Canada approval

Nov. 12, 2001

Vical receives HIV vaccine milestone payment

Nov. 8, 2001

Favorable sixth phase III safety review of VaxGen's AIDS vaccine

Nov. 5, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 23, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...